13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 68 holding rows worth $998,838,000.
- Accession
- 0001802630-22-000003
- Filer
- CIK 1802630
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 68 entries on the cover page, a total value of $998,838,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $998,836,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 1,292,000 | $144,652,000 | thousands by filing date | put |
| iShares Russell 2000 ETF | 464287655 | SHS | 508,500 | $113,116,000 | thousands by filing date | put |
| LANTHEUS HLDGS INC | 516544103 | COM | 1,764,627 | $50,980,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 3,525,457 | $50,061,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 2,515,424 | $49,378,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 164,300 | $35,502,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 478,596 | $27,878,000 | thousands by filing date | |
| Surmodics Inc | 868873100 | Common Stock | 532,757 | $25,652,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 318,275 | $23,801,000 | thousands by filing date | |
| THERATECHNOLOGIES INC COM | 88338H100 | COM | 7,692,082 | $23,307,000 | thousands by filing date | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,309,003 | $23,275,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,550,497 | $21,862,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 743,238 | $21,517,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 227,599 | $21,255,000 | thousands by filing date | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 450,030 | $20,796,000 | thousands by filing date | |
| SMITH & NEPHEW PLC SPDN ADR NEW | 83175M205 | ADR | 593,200 | $20,537,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 810,940 | $20,525,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 2,295,100 | $19,348,000 | thousands by filing date | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 3,148,609 | $18,860,000 | thousands by filing date | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 1,999,087 | $18,472,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 561,122 | $18,068,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,068,376 | $17,863,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 228,437 | $15,979,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 138,000 | $14,236,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 515,450 | $14,216,000 | thousands by filing date | |
| STERIS PLC SHS USD | G8473T100 | Stock | 52,100 | $12,682,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 378,997 | $11,840,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 962,165 | $11,767,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 1,258,889 | $8,195,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 477,495 | $7,640,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 294,750 | $7,012,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 1,891,878 | $6,943,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 27,450 | $6,315,000 | thousands by filing date | |
| BIOVENTUS INC | 09075A108 | COM CL A | 428,397 | $6,207,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 101,600 | $6,113,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 98,800 | $5,447,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 427,200 | $5,203,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 310,494 | $5,033,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 298,700 | $4,872,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 51,000 | $4,378,000 | thousands by filing date | |
| IO BIOTECH INC | 449778109 | COM | 672,734 | $4,305,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 7,759 | $4,166,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 338,760 | $4,028,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 27,500 | $3,724,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 40,000 | $3,718,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 86,180 | $3,561,000 | thousands by filing date | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 350,000 | $3,434,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 1,644,500 | $3,371,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 300,000 | $2,975,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 175,152 | $2,846,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 687,412 | $2,598,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 158,700 | $2,490,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 68,320 | $2,488,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 90,000 | $1,779,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 175,000 | $1,675,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 22,275 | $1,672,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 22,000 | $1,667,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 1,950,000 | $1,443,000 | thousands by filing date | principal |
| AVALO THERAPEUTICS INC | 05338F108 | CMN | 770,000 | $1,309,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 231,485 | $1,127,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 11,000 | $904,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 64,585 | $769,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 10,250 | $624,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 7,800 | $456,000 | thousands by filing date | |
| CELCUITY INC | 15102K100 | COM | 32,073 | $423,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 13,000 | $230,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 2,850 | $227,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 10,000 | $44,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-22-000003 | this filing | 2022-02-14 | acceptance time not in the bulk data set |